SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Gujarat Kidney And Super Speciality Ltd (GKSL)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 544666 NSE: GKSL Hospital & Healthcare Services | Small Cap | Guj. Kidney & Super Share Price

₹131.10 -1.45 (-1.09%)

As on 04-Jun'26 16:59

Gujarat Kidney And Super Speciality Ltd (GKSL)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 544666 NSE: GKSL Hospital & Healthcare Services | Small Cap | Guj. Kidney & Super Share Price

₹131.10 -1.45 (-1.09%)

As on 04-Jun'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹1,034 Cr.
Current Price
₹131.1
52-Week Low / High
₹98 / 148
TTM EPS
₹1.3
TTM Sales
₹40.1 Cr.
Book Value per Share
₹31.3
P/E Ratio
104.40
Lower than its 5-year historical median
Industry PE
87
Price to Book (P/B)
4.19
Price to Sales (P/S)
25.78
Lower than its 5-year historical median
EV/EBITDA
59.95
Lower than its 5-year historical median
Dividend Yield
0.00%
Profitability Efficiency
Return on Equity (ROE)
131.97%
Outperforms industry median
Return on Capital Employed (ROCE)
30.01%
Outperforms industry median
Return on Assets (ROA)
14.14%
Operating Profit Margin
31.4%
Net Profit Margin
29.19%
Gross Profit Margin
44.7%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
-
-
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
71.45%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹231 Cr.
Equity
₹15.8 Cr.
Face Value
₹2
All Time Low / High
₹98.25 / 148.45

Gujarat Kidney And Super Speciality stock performance

Key Ratios
mw4me loader

Check Before You Invest

Valuation

Undervalued

Price Trend

Strong
Q.1 Is Gujarat Kidney And Super Speciality Ltd a good quality company?
Gujarat Kidney And Super Speciality Ltd is a weak quality company, based on a inconsistent multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Gujarat Kidney And Super Speciality Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Gujarat Kidney And Super Speciality Ltd vs industry peers?
Gujarat Kidney And Super Speciality Ltd revenue CAGR is %, compared to the industry median CAGR of 6.53%, indicating slower growth and losing its market share.
Q.1 Promoter shareholding and pledge status of Gujarat Kidney And Super Speciality Ltd?
Promoters hold 71.45% of the Gujarat Kidney And Super Speciality Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Gujarat Kidney And Super Speciality Ltd over the last decade?
Over the last - year(s), the stock has delivered a CAGR of N/A% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Gujarat Kidney And Super Speciality Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Mar'22Mar'23Mar'24TTM
ROCE % 38.4%-1.7%30%-
Value Creation
Index
1.7-1.11.1-

Growth Parameters

Sales 0.80540
Sales YoY Gr.--100%NA-
Adj EPS 0-00.31.3
YoY Gr.--100%NA-
BVPS (₹) 0.10.10.531.3
Adj Net
Profit
0.1-0110
Cash Flow from Ops. 00-2.1-
Debt/CF from Ops. 00-0.9-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales NANANANA
Adj EPS NANANANA
BVPSNANANA372.7%
Share Price - - - -

Key Financial Parameters

Mar'22Mar'23Mar'24TTM
Return on
Equity %
25.9-1.617.17.9
Op. Profit
Mgn %
91.3031.433.1
Net Profit
Mgn %
12.5019.324.8
Debt to
Equity
001.10
Working Cap
Days
00255314
Cash Conv.
Cycle
00-268149

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24
Sales105
Operating Expenses + 003
Manufacturing Costs000
Material Costs000
Employee Cost 001
Other Costs 002
Operating Profit 1-02
Operating Profit Margin (%) 91.3%-31.4%
Other Income + 001
Exceptional Items 000
Interest 000
Depreciation 100
Profit Before Tax 0-02
Tax 000
Profit After Tax 0-01
PAT Margin (%) 12.5%-29.2%
Adjusted EPS (₹)0.00.00.4
Dividend Payout Ratio (%)0%0%0%

Valuation of Guj. Kidney & Super - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund + 002
Share Capital 000
Reserves 002
Debt +002
Long Term Debt002
Short Term Debt000
Minority Interest000
Trade Payables332
Others Liabilities 0-011
Total Liabilities 4417

Fixed Assets

Net Fixed Assets +3310
Gross Block4410
Accumulated Depreciation110
CWIP 000
Investments 000
Inventories000
Trade Receivables114
Cash Equivalents 001
Others Assets 001
Total Assets 4417

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24
Cash Flow From Operating Activity + 00-2
PBT 0-02
Adjustment 100
Changes in Working Capital -10-4
Tax Paid -00-1
Cash Flow From Investing Activity + 00-7
Capex 00-7
Net Investments 000
Others 000
Cash Flow From Financing Activity + 0011
Net Proceeds from Shares 009
Net Proceeds from Borrowing 002
Interest Paid 00-0
Dividend Paid 000
Others 000
Net Cash Flow 001

Financial Ratio

PARTICULARSMar'22Mar'23Mar'24
Ratios
ROE (%)N/AN/A131.97
ROCE (%)N/AN/A30.01
Asset Turnover Ratio0.200.48
PAT to CFO Conversion(x)N/AN/A-2
Working Capital Days
Receivable Days5390194.50
Inventory Days0019.80
Payable Days003,487.50

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Gujarat Kidney And Super Speciality Ltd FAQs

The current trading price of Guj. Kidney & Super on 04-Jun-2026 16:59 is ₹131.1.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Jun-2026 the market cap of Guj. Kidney & Super stood at ₹1,033.6 Cr

The latest P/E ratio of Guj. Kidney & Super as of 03-Jun-2026 is 104.4.

The latest P/B ratio of Guj. Kidney & Super as of 03-Jun-2026 is 4.19.

The 52-week high of Guj. Kidney & Super is ₹148.4 and the 52-week low is ₹98.25.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Guj. Kidney & Super is ₹40.10 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Gujarat Kidney And Super Speciality Ltd is a below average quality company.

The key valuation ratios of Gujarat Kidney And Super Speciality Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Gujarat Kidney And Super Speciality Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

About Gujarat Kidney And Super Speciality Ltd

Gujarat Kidney and Super Speciality was incorporated under the name and style of ‘Vihaan Medicare Private Limited’, a private limited company on December 20, 2019. Subsequently, in order to align its name with the business carried out by the company of offering multi-speciality and super-speciality medical services, pursuant to a resolution passed by the board of directors in their meeting held on September 04, 2023, and by the shareholders in an extraordinary general meeting held on September 06, 2023, the name of the company was changed to ‘Gujarat Kidney and Super Speciality Private Limited’ on September 13, 2023. Further, the company was converted into a public limited company pursuant to a resolution passed by the board of directors in their meeting held on November 02, 2023 and by the Shareholders in an extraordinary general meeting held on November 04, 2023 and consequently the name of the company was changed to ‘Gujarat Kidney and Super Speciality Limited’.

The company operates a chain of mid-sized multi-speciality hospitals, providing integrated healthcare services, with a focus on secondary (which are surgical services) and tertiary care (which are super speciality surgical services). Its hospitals provide integrated diagnostic services, either in-house, and pharmacies that cater to its patients. It endeavours to provide quality and affordable healthcare services to all its patients. The company wholly owns some of the hospitals but manage the operations of each of the hospitals through a separate professional management team. Each of its hospitals is managed by a Chief Operating Officer, who is responsible for supervising day to day functioning. This structure provides the company with greater control over its hospitals and helps it to deliver quality healthcare services.

The company is led by Pragnesh Yashwantsingh Bharpoda, who has vast experience in the medical industry. He has helped the company expand its geographical presence by strategically acquiring various multi-speciality hospitals, over the years.

Business area of the company 

The company, along with its subsidiaries, is a multi-specialty healthcare institution and is engaged in providing comprehensive medical services, including inpatient and outpatient care, surgical procedures, diagnostic services, and emergency care. 

Services of the company

Specialities services

  • General Medicine
  • General Surgery
  • Laparoscopic Surgery
  • Metabolic and Obesity Surgery
  • IVF
  • Obstetric and Gynaecology (OBGY)
  • Ortho
  • Joint Replacement
  • Arthroscopy
  • Endocrinology
  • Diabetology
  • Pulmonology
  • Intensivist
  • Skin and VD
  • Radiology
  • Pathology
  • Psychiatrist
  • Paediatric
  • Ophthalmology
  • ENT
  • Physiotherapy
  • Dietician

Super Specialities services

  • Urology
  • Cardiology
  • Nephrology
  • Neurology
  • Neuro Surgery
  • Oncology
  • Onco Surgery
  • Renal Transplant
  • Vascular Surgery
  • Gastroenterology
  • Gastro Surgery
  • Plastic Surgery
  • Paediatric Surgery
  • Hematology
  • Spine Surgery

Awards, accreditations and recognition 

  • 2022: Registration of Gujarat Kidney Hospital with the Kidney Transplant Center under the Human Organs Transplantation Act, 1994.
  • 2023: Renewal of registration of Gujarat Kidney Hospital with Kidney Transplant Center under the Human Organs Transplantation Act, 1994.
  • 2023: Accreditation for its Gujarat Kidney Hospital by the National Accreditation Board for Hospital & Healthcare Provide.

History and milestones

  • 2014: Established and commenced operations of its first hospital under the name of ‘Gujarat Kidney Hospital’ at Vadodara, Gujarat.
  • 2018: Shifted Gujarat Kidney Hospital to a larger premises in Vadodara, Gujarat to expand the bed capacity from fifteen to sixty-five.
  • 2018: Established five sub-specialities in its uro department, viz., endourology, urologic oncology, paediatric urology, reconstructive urology, and laparoscopic urology at its Gujarat Kidney Hospital.
  • 2019: Set up an in-house interventional cardiology department under the name of ‘Gujarat Heart Care Unit’ for offering invasive cardiology services.
  • 2021: Successfully carried out its first laparoscopic radical prostatectomy at its Gujarat Kidney Hospital.
  • 2023: Established and commenced operations of its second hospital in Godhra, Gujarat.
  • 2023: Successfully carried out its first renal transplant at its Gujarat Kidney Hospital.
  • 2023: Successfully carried out its first Angiography at its Godhra Hospital.
  • 2023: Established three in-house super-speciality departments for cardiology, urology and nephrology at its Godhra Hospital.
  • 2024: Successfully carried out its first retrograde intrarenal surgery (RIRS) at its Godhra Hospital.
  • 2024: Acquired majority stake in Raj Palmland Hospital Private Limited, thereby making it the company’s Subsidiary.
  • 2024: Acquired the Gujarat Kidney Hospital.
  • 2024: Acquired the Godhra Hospital.
  • 2024: Acquired controlling interest of 90% in M/s Surya Hospital and ICU.
  • 2024: Acquired controlling interest of 90% in M/s. Gujarat Surgical Hospital.
  • 2025: Acquired Ashwini Medical Centre.
  • 2025: Acquired Ashwini Medical Store.
  • 2025: Acquired 51% of equity shares of Harmony Medicare Private Limited.

You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×